[1]
I. Proietti, E. Tolino, N. Bernardini, M. Di Fraia, N. Skroza, and C. Potenza, “Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome”, Dermatol Pract Concept, vol. 13, no. 3, p. e2023178, Jul. 2023, doi: 10.5826/dpc.1303a178.